Japanese Journal of Cancer Research · 1997 · 106 citations · 19 references
MedicineOncologyPharmacologyCancer PharmacologyCancer PreventionGastrointestinal OncologyCancer ChemopreventionColorectal CancerGastrointestinal ToxicityOncology PharmacologyColon Tumor PromotionColorectal Cancer ChemopreventionColorectal Carcinogenesis PathophysiologyLactoferrin Activity
The influence of bovine lactoferrin (bLF) on colon carcinogenesis was investigated in male F344 rats treated with azoxymethane (AOM). Following three weekly injections of AOM, the animals received 2 or 0.2% bLF for 36 weeks. No effects indicative of toxicity were noted, but significant reduction in both the incidence and number of adenocarcinomas of the large intestine was observed with both doses. Thus, the incidences of adenocarcinomas in the groups receiving 2% and 0.2% bLF were 15% and 25%, respectively, in contrast to the 57.5% control value (P < 0.01 and P < 0.05, respectively). The results indicate that bLF might find application for chemoprevention of colon cancer.
19
Lactoferrin: a general review.
PF Levay, Margaretha Viljoen · PubMed · 1995 · 652 citations
Potent Antibacterial Peptides Generated by Pepsin Digestion of Bovine Lactoferrin
Mamoru TOMITA, Wayne Bellamy, Mitsunori Takase et al. · Journal of Dairy Science · 1991 · 444 citations · Full text
Inhibition of carcinogenesis by minor dietary constituents.
Lee W. Wattenberg · PubMed · 1992 · 400 citations
Medicine, Oncology, Pharmacology +15
Lactoferrin: a multifunctional immunoregulatory protein?
Jeremy H. Brock · Immunology Today · 1995 · 232 citations
Joann Bezault, Ramesh Bhimani, J. Wiprovnick et al. · PubMed · 1994 · 203 citations
Medicine, Oncology, Pharmacology +14